» Articles » PMID: 36046670

Dynamic Culture of Mesenchymal Stromal/Stem Cell Spheroids and Secretion of Paracrine Factors

Overview
Date 2022 Sep 1
PMID 36046670
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, conditioned medium (CM) obtained from the culture of mesenchymal stromal/stem cells (MSCs) has been shown to effectively promote tissue repair and modulate the immune response and in different animal models, with potential for application in regenerative medicine. Using CM offers multiple advantages over the implantation of MSCs themselves: 1) simpler storage, transport, and preservation requirements, 2) avoidance of the inherent risks of cell transplantation, and 3) potential application as a ready-to-go biologic product. For these reasons, a large amount of MSCs research has focused on the characterization of the obtained CM, including soluble trophic factors and vesicles, preconditioning strategies for enhancing paracrine secretion, such as hypoxia, a three-dimensional (3D) environment, and biochemical stimuli, and potential clinical applications. preconditioning strategies can increase the viability, proliferation, and paracrine properties of MSCs and therefore improve the therapeutic potential of the cells and their derived products. Specifically, dynamic cultivation conditions, such as fluid flow and 3D aggregate culture, substantially impact cellular behaviour. Increased levels of growth factors and cytokines were observed in 3D cultures of MSC grown on orbital or rotatory shaking platforms, in stirred systems, such as spinner flasks or stirred tank reactors, and in microgravity bioreactors. However, only a few studies have established dynamic culture conditions and protocols for 3D aggregate cultivation of MSCs as a scalable and reproducible strategy for CM production. This review summarizes significant advances into the upstream processing, mainly the dynamic generation and cultivation of MSC aggregates, for de CM manufacture and focuses on the standardization of the soluble factor production.

Citing Articles

Standardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model.

Wolint P, Hofmann S, von Atzigen J, Boni R, Miescher I, Giovanoli P Int J Mol Sci. 2025; 26(1.

PMID: 39796147 PMC: 11719671. DOI: 10.3390/ijms26010291.


Dynamically cultured, differentiated bovine adipose-derived stem cell spheroids as building blocks for biofabricating cultured fat.

Klatt A, Wollschlaeger J, Albrecht F, Ruhle S, Holzwarth L, Hrenn H Nat Commun. 2024; 15(1):9107.

PMID: 39438462 PMC: 11496621. DOI: 10.1038/s41467-024-53486-w.


Completely noninvasive multi-analyte monitoring system for cell culture processes.

Rahmatnejad V, Tolosa M, Ge X, Rao G Biotechnol Lett. 2024; 46(6):983-996.

PMID: 39162863 PMC: 11550249. DOI: 10.1007/s10529-024-03521-z.


Mechanical force regulates the paracrine functions of ADSCs to assist skin expansion in rats.

Xue Z, Hu D, Tang H, Xue M, Zhu Y, Li Y Stem Cell Res Ther. 2024; 15(1):250.

PMID: 39135129 PMC: 11321134. DOI: 10.1186/s13287-024-03822-0.


The issue of heterogeneity of MSC-based advanced therapy medicinal products-a review.

cesnik A, Svajger U Front Cell Dev Biol. 2024; 12:1400347.

PMID: 39129786 PMC: 11310176. DOI: 10.3389/fcell.2024.1400347.


References
1.
He H, He Q, Xu F, Zhou Y, Ye Z, Tan W . Dynamic formation of cellular aggregates of chondrocytes and mesenchymal stem cells in spinner flask. Cell Prolif. 2019; 52(4):e12587. PMC: 6669002. DOI: 10.1111/cpr.12587. View

2.
Ringden O, Moll G, Gustafsson B, Sadeghi B . Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Front Immunol. 2022; 13:839844. PMC: 8973075. DOI: 10.3389/fimmu.2022.839844. View

3.
Luz-Crawford P, Torres M, Noel D, Fernandez A, Toupet K, Alcayaga-Miranda F . The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells. 2015; 34(2):456-69. DOI: 10.1002/stem.2244. View

4.
von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B . Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012; 30(7):1575-8. DOI: 10.1002/stem.1118. View

5.
Dong J, Gu Y, Li C, Wang C, Feng Z, Qiu R . Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Acta Pharmacol Sin. 2009; 30(5):530-6. PMC: 4002825. DOI: 10.1038/aps.2009.40. View